O2Fast is a safe and easy to use solution that produces medically pure oxygen from two dry inert, proprietary powders. O2Fast is owned by Kwivik Therapeutics, Inc. which owns numerous patents issued and pending on this proprietary process and methodology that is revolutionizing the emergency short duration oxygen supply marketplace. With this technology, oxygen is generated on demand. There is no storage of oxygen. There are no compressed tanks, no dials, no valves, no regulatory maintenance, no hydrostatic testing, no batteries, no required training, and none of the hazards associated with traditional oxygen provision systems. The O2Fast system makes the delivery devices lighter, safer, more affordable and easier to use.
O2Fast improves access to emergency oxygen that affects the survival, recovery and safety of individuals in several areas of need: (1) Public and private places and settings where medical emergencies can occur; (2) Individuals at risk for cardiac, respiratory or general medical distress needing immediate help prior to emergency medical care arrival; and (3) Those requiring immediate protection and escape from exposure situations or oxygen-deficient situations in industrial, mining, military, or other "Immediately Dangerous to Life or Health” (IDLH) environments.
O2Fast is the world's first premier portable emergency oxygen device for mass lay person use. It allows any lay person - a bystander, colleague or loved one - to administer medical oxygen during those first critical minutes after a medical emergency occurs, while waiting for first responders to arrive. The technology has already been used in thousands of saves.
O2Fast is also an excellent companion product to Automated External Defibrillators (AEDs).
Important: O2Fast is a Class II medical device is not yet approved by the U.S. FDA. Therefore, it cannot be legally marketed in the U.S.A. and is not available for sale in the U.S.A.